HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.

AbstractOBJECTIVE:
We examined the effects of fluvastatin treatment on the development of kidney injury in experimental deoxycorticosterone-acetate (DOCA)-salt hypertension.
METHODS:
Male Sprague-Dawley rats underwent unilateral nephrectomy and received subcutaneous DOCA pellets as well as 1% NaCl for drinking. Simultaneously, rats were treated with 5 mg/kg per day fluvastatin, or solvent only for 6 weeks. Mean arterial pressure was measured intraarterially. Glomerulosclerosis, interstitial fibrosis, cell proliferation, inflammation and podocyte damage were evaluated on kidney sections. Inflammatory markers were measured by real-time PCR.
RESULTS:
Mean arterial pressure was elevated in DOCA-salt-treated rats but unaltered by fluvastatin. Serum cholesterol was markedly elevated in DOCA-salt-treated rats and tended to be lower in fluvastatin-treated animals. Fluvastatin treatment decreased the mortality of DOCA-salt-treated rats. Urinary protein excretion, glomerular proliferation and macrophage infiltration as well as glomerulosclerosis were reduced by fluvastatin. Fluvastatin alleviated podocyte damage and glomerular osteopontin protein expression, which was localized in podocytes. On the contrary, interstitial fibrosis, inflammation and interstitial cell proliferation of DOCA-salt-treated rat kidneys were not influenced by fluvastatin.
CONCLUSION:
Statin treatment reduces mortality and glomerular damage independent from blood pressure in a low-renin model of hypertensive nephrosclerosis. A reduction of podocyte damage and macrophage infiltration may explain the beneficial effects of fluvastatin.
AuthorsAndrea Hartner, Bernd Klanke, Nada Cordasic, Kerstin Amann, Roland E Schmieder, Roland Veelken, Karl F Hilgers
JournalJournal of hypertension (J Hypertens) Vol. 27 Issue 2 Pg. 376-85 (Feb 2009) ISSN: 0263-6352 [Print] England
PMID19226708 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids, Monounsaturated
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Indoles
  • Desoxycorticosterone
  • Fluvastatin
Topics
  • Animals
  • Blood Pressure
  • Cell Proliferation
  • Desoxycorticosterone
  • Disease Progression
  • Fatty Acids, Monounsaturated (pharmacology, therapeutic use)
  • Fluvastatin
  • Glomerulonephritis (etiology, prevention & control)
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (pharmacology, therapeutic use)
  • Hypertension (drug therapy, etiology, metabolism, pathology)
  • Indoles (pharmacology, therapeutic use)
  • Kidney (pathology)
  • Male
  • Nephrosclerosis (etiology, prevention & control)
  • Organ Size
  • Podocytes (drug effects, pathology)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: